ACT Genomics Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 10

ACT Genomics General Information

Description

Provider of cancer molecular information services designed to rewrite the existing model of diagnostic, treatment, and monitoring. The company's cancer molecular information services implement next-generation sequencing and multiplex molecular testing, coupled with bioinformatics tools, curated proprietary databases and data visualization technologies, enabling oncologists to address the key challenges in cancer treatments.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Medical Records Systems
Primary Office
  • 3 Floor, Number 345
  • Xinhu 2nd Road
  • Taipei City, Neihu District 114
  • Taiwan
+886 02 0000 0000

ACT Genomics Timeline

2018201920202021
Financing RoundFinancing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ACT Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 08-Sep-2020 0000 Completed Profitable
3. Early Stage VC 26-Sep-2018 000.00 0000 Completed Startup
2. Early Stage VC (Series B) 01-May-2016 $12.5M $20.5M Completed Startup
1. Early Stage VC (Series A) 13-Feb-2015 $8M $8M Completed Startup
To view ACT Genomics’s complete valuation and funding history, request access »

ACT Genomics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of cancer molecular information services designed to rewrite the existing model of diagnostic, treatment, and m
Monitoring Equipment
Taipei City, Taiwan
0000
0000000000 0 0000

00000000

velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, s
0000000000 000000000
Hyderabad, India
00.000
0000000000 00.000

000000 (

usmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exer
0000000000000 00000000
Bangalore, India
000 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ACT Genomics Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Theranosis Life Sciences Accelerator/Incubator Backed Hyderabad, India 00.000 0000000000 00.000
000000 (0000000000 Venture Capital-Backed Bangalore, India 000 000.00 0000000000 0 000.00
00000 00000000 Private Equity-Backed Aliso Viejo, CA 000 000000&0
0000 00 0000 Accelerator/Incubator Backed Houston, TX 00 000000&0
000000000 Venture Capital-Backed Foster City, CA 000 00000 000000 - 000 00000
You’re viewing 5 of 7 competitors. Get the full list »

ACT Genomics Executive Team (5)

Name Title Board Seat Contact Info
PJ Hsueh Chief Operating Officer
Hua Chien Chen Ph.D Co-Founder and Chief Executive Officer
Victor Chan Chief Financial Officer
Shu-Jen Chen Ph.D Co-Founder & Chief Scientific Officer
To view ACT Genomics’s complete executive team members history, request access »

ACT Genomics Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Aflac Innovation Partners Corporate Venture Capital Minority 000 0000 000000 0
Kyoto University Innovation Capital Other Minority 000 0000 000000 0
CLSA Capital Partners Real Estate Minority 000 0000 000000 0
HKSTP Ventures Corporate Venture Capital Minority 000 0000 000000 0
CDIB Capital International PE/Buyout Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

ACT Genomics Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 01-Mar-2017 00000 0000000 Biotechnology
To view ACT Genomics’s complete investments history, request access »

ACT Genomics Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 01-Mar-2017 00000 0000000 Completed
  • 2 buyers
To view ACT Genomics’s complete exits history, request access »